We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Adaptimmune Appoints Lawrence M. Alleva to its Board of Directors

News   Mar 11, 2015

 
Adaptimmune Appoints Lawrence M. Alleva to its Board of Directors
 
 
 

RELATED ARTICLES

Device Would Allow TB Dosing to Switch From Daily to Monthly

News

A drug delivery device is under development, which works by slowly releasing antibiotics directly into the patient's stomach. This would allow patients to switch from daily to monthly doses, reducing the burden of tuberculosis treatment.

READ MORE

Response to Skin Fungi Pivotal in Dermatitis Pathway

News

How does the immune system respond to fungi on our skin? Researchers at the University of Zurich have demonstrated that the same immune cells that protect us against skin fungi also encourage the inflammatory symptoms of atopic dermatitis. An antibody therapy could alleviate this chronic inflammatory skin disease.

READ MORE

"Inflamm-aging" Results in Loss of Bone-healing Ability in the Elderly

News

The current study explains how this age-driven increase in immune signals diminishes the ability of stem cells, essential ingredients in bone repair, to multiply.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE